Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

Published:2021-04-16 Issue:6 Volume:37 Page:891-902
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Deitelzweig Steven¹²,Di Fusco Manuela³^ORCID,Kang Amiee⁴,Savone Mirko³,Mokgokong Ruth⁵,Keshishian Allison⁶,Gutierrez Cynthia⁶,Cappelleri Joseph C.⁷^ORCID

Affiliation:

1. Department of Hospital Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA

2. Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA

3. Pfizer, Inc, New York, NY, USA

4. Bristol-Myers Squibb Company, Lawrenceville, NJ, USA

5. Pfizer, Inc, Tadworth, Surrey, UK

6. STATinMED Research, Ann Arbor, MI, USA

7. Pfizer, Inc, Groton, CT, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1897555

Reference75 articles.

1. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. A Patient’s Guide to Living With Atrial Fibrillation

3. Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

4. Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

5. How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2023-06-18

2. Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban;JACC: Advances;2023-01

3. Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences;Systematic Reviews;2022-10-28

4. Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study;Clinical and Applied Thrombosis/Hemostasis;2022-01

5. Can We Anticipate Nonadherence to Anticoagulation?;Journal of the American College of Cardiology;2021-12